Page last updated: 2024-09-03

imatinib mesylate and Aphthae

imatinib mesylate has been researched along with Aphthae in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boralevi, F; Fricain, JC; Sibaud, V; Vigarios, E1
Akin Belli, A; Ayer, M; Barut, SG; Dervis, E1

Reviews

1 review(s) available for imatinib mesylate and Aphthae

ArticleYear
[Oral toxicity of targeted anticancer therapies].
    Annales de dermatologie et de venereologie, 2014, Volume: 141, Issue:5

    Topics: Angiogenesis Inhibitors; Benzamides; ErbB Receptors; Glossitis, Benign Migratory; Humans; Hyperpigmentation; Imatinib Mesylate; Indoles; Maxillary Diseases; Molecular Targeted Therapy; Mouth Mucosa; Osteonecrosis; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyrimidines; Pyrroles; Radiation Injuries; Radiotherapy; Stomatitis; Stomatitis, Aphthous; Sunitinib; TOR Serine-Threonine Kinases

2014

Other Studies

1 other study(ies) available for imatinib mesylate and Aphthae

ArticleYear
Cutaneous adverse reactions of imatinib therapy in patients with chronic myeloid leukemia: A six-year follow up.
    European journal of dermatology : EJD, 2016, Apr-01, Volume: 26, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents; Cheilitis; Cross-Sectional Studies; Drug Eruptions; Edema; Exanthema; Female; Follow-Up Studies; Humans; Hyperhidrosis; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Pigmentation Disorders; Stomatitis, Aphthous; Time Factors; Young Adult

2016